Wednesday, July 06, 2016 1:06:29 PM
Taylor Cox , Benzinga Staff Writer-July 06, 2016 9:00am
Click For Article
The Wall Street Journal recently reported President Obama’s administration will loosen its strict controls on a medication called buprenorphine, which is used to treat addiction to heroin and other opioid-based drugs.
The Department of Health and Human Services up until now only allowed doctors to prescribe the medication to 100 patients at a time. Under the new rules, up to 275 patients at a time can be prescribed the drug. The limits were designed to restrict access to the substance, which addicts sometimes trade on the black market to opioid abusers seeking to avoid painful withdrawal symptoms. An unintended consequence to the tight controls became the inability/difficulties of finding a legal way to obtain the medicine from a doctor.
Related Link: Heat Wave: Here's How The S&P Has Performed Every July Since The Financial Crisis
This could spell good news for companies like Titan Pharmaceuticals, Inc.
TTNP 0.85%
and BioDelivery Sciences International, Inc.
BDSI 4.26%
, two companies that have been working on an injectable form of buprenorphine.
Titan recently received approval from the FDA for the first injectable implant in the United States, which will deliver a dosage of the medicine to patients, especially those who find methadone to be too addicting.
Shares of both Titan and BioDelivery over the last month have spiked but fallen to remain pretty much flat; however, this news may be a catalyst for these two pharmaceuticals.
Blessings to All
TRUTH
I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of them.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM